ATENOLOL AND CHLORTHALIDONE

Post-LOE

atenolol and chlorthalidone tablet

Novitium Pharma

ANDAORALTABLET

Approved

Oct 2021

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

ATENOLOL AND CHLORTHALIDONE (atenolol and chlorthalidone tablet) by Novitium Pharma is adrenergic beta-antagonists [moa]. Approved for hypertension, to lower blood pressure, heart failure. First approved in 2021.

Drug data last refreshed 15h ago

Mechanism of Action

Adrenergic beta-Antagonists

Pharmacologic Class:

Thiazide-like Diuretic

Indications (3)

hypertension to lower blood pressure heart failure

Worked on ATENOLOL AND CHLORTHALIDONE at Novitium Pharma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.